Less is More in Antithrombotic Therapy for Durable Left Ventricular
Assist Devices

Matthew   T.   Brown; Nanette   K.   Wenger

doi:10.2174/011573403X307310240404062647

Less is More in Antithrombotic Therapy for Durable Left Ventricular Assist Devices

Volume 20, Issue 6, 2024

Published on: 15 April, 2024

Article ID: e150424228882 Pages: 3

DOI: 10.2174/011573403X307310240404062647

Keywords: Aspirin, atherosclerotic cardiovascular disease, vitamin K antagonist, left ventricular assist device, HeartMate 3, mechanical heart valves.

Download Options

Rights & Permissions Print Cite

Current Cardiology Reviews

Title:Less is More in Antithrombotic Therapy for Durable Left Ventricular Assist Devices

Volume: 20 Issue: 6

Author(s): Matthew T. Brown*Nanette K. Wenger*

Affiliation:

Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia

Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia

Keywords: Aspirin, atherosclerotic cardiovascular disease, vitamin K antagonist, left ventricular assist device, HeartMate 3, mechanical heart valves.

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Brown T. Matthew*, Wenger K. Nanette*, Less is More in Antithrombotic Therapy for Durable Left Ventricular Assist Devices, Current Cardiology Reviews 2024; 20 (6) : e150424228882 . https://dx.doi.org/10.2174/011573403X307310240404062647

DOI https://dx.doi.org/10.2174/011573403X307310240404062647	Print ISSN 1573-403X
Publisher Name Bentham Science Publisher	Online ISSN 1875-6557

About this journal

Call for Papers in Thematic Issues

Submission closes on : 10 December, 2024

The era of cardiac medication and implantable devices therapy in heart failure treatment continues

The heart failure (HF) remains a serious public health problem and affects 64 million people worldwide. Although advances in medical therapy and device assistance have significantly improved the HF outcomes, implications of HF are still dramatic. In recent years, innovative developments have been made in the HF treatment management, based ...read more

Guest Editor(s): Tariel Atabekov